Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

N4 Pharma Plc (N4P) Share News

123456

N4 Pharma shares fall as places shares to fund Nanogenics stake buy

28th Sep 2023 10:20

(Alliance News) - N4 Pharma PLC on Thursday said it bought a controlling interest in Nanogenics Ltd, a company with a lipid and peptide-based delivery system called Liptide. Read More

N4 Pharma interim loss narrows slightly as business outreach ongoing

12th Sep 2023 13:43

(Alliance News) - N4 Pharma PLC on Tuesday said its business outreach is ongoing as it continued to work on getting Nuvec, its delivery system for vaccines and cancer treatment, into clinic. Read More

LONDON MARKET MIDDAY: Miners lift FTSE 100 as Fed meeting kicks off

25th Jul 2023 12:08

(Alliance News) - Stock prices in London were largely higher at midday on Tuesday, with stimulus talks in China helping lift the mood, as attention turns to the US Federal Reserve which begins its two-day monetary policy meeting later. Read More

N4 Pharma shares soar on further patent grant for Nuvec in US

25th Jul 2023 10:12

(Alliance News) - N4 Pharma PLC on Tuesday saw its shares rise, as it celebrated a patent grant for Nuvec in the US. Read More

AIM WINNERS & LOSERS: N4 Pharma shares jump on grant of US patent

25th Jul 2023 10:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

IN BRIEF: N4 Pharma expands Professor Yu partnership on grant award

27th Jun 2023 12:13

N4 Pharma PLC - Derby, England-based pharmaceutical company focused on developing Nuvec, a delivery system for vaccines and cancer treatments - Says it will be supporting the University of Queensland as part of a recent grant award by the Australian Research Council. Professor Chengzhong Yu, senior group leader at the Australian Institute for Bioengineering & Nanotechnology, has been awarded an AUD402,115 grant - around GBP211,366 - to develop an improved nanoparticle delivery system that enhances the performance of messenger ribonucleic acid therapies. Read More

TRADING UPDATES: Eckoh expects profit up; LXi REIT refinances facility

25th Apr 2023 16:19

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: FireAngel 2023 earnings below expectations

25th Apr 2023 10:30

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

TRADING UPDATES: Journeo extends contract; Biome completes fundraise

18th Apr 2023 14:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

27th Mar 2023 15:50

Read More

EARNINGS SUMMARY: Franchise Brands blooms; Tlou Energy loss widens

9th Mar 2023 14:32

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares

17th Jan 2023 16:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Parsley Box to exit AIM as shares wilt since IPO

18th Nov 2022 11:16

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

N4 Pharma plummets on broker offer to raise up to GBP1 million

18th Nov 2022 11:02

(Alliance News) - N4 Pharma PLC shares plummeted on Friday, after it raised GBP1.0 million through a placing of 50.0 million shares and announced a broker offer to raise up to GBP1.0 million. Read More

IN BRIEF: N4 Pharma expands patent application claims for Nuvec

1st Nov 2022 17:06

N4 Pharma PLC - Derby, England-based pharmaceutical company focused on developing Nuvec, a delivery system for vaccines and cancer treatments - Provides a patent application update for Nuvec. Read More

AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles

4th Oct 2022 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

N4 Pharma announces successful test in next stage of Nuvec development

4th Oct 2022 10:38

(Alliance News) - N4 Pharma PLC on Tuesday announced successful in vitro testing of Nuvec when loaded with two small interfering siRNA probes. Read More

LONDON MARKET OPEN: Stocks rise as market sentiment recovers

4th Oct 2022 08:46

(Alliance News) - Stock prices in London opened sharply higher on Tuesday, lifted by more positive market sentiment following the UK government's tax U-turn, as well as some positive trading updates. Read More

EARNINGS UPDATES: Crestchic raises outlook on record year-to-date

29th Sep 2022 15:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: N4 completes testing on loading Nuvec drug with siRNA probes

14th Sep 2022 12:03

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company - Completes initial testing on loading its Nuvec treatment with two generic siRNA probes at the same time. siRNA can prevent cells from communicating, potentially preventing cancer cells from replicating. N4 are now undertaking experiments using siRNA sequences against known oncology targets. This includes in vitro using a lung cancer cell line and, after that, in vivo studies in mice. Chief Executive Officer Nigel Theobald said: "We have now identified a very strong commercial point of difference for Nuvec in that it can be successfully loaded with at least two siRNA genes". Read More

123456
FTSE 100 Latest
Value8,809.74
Change53.53